These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

855 related items for PubMed ID: 20236142

  • 1. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
    Bellingham MC.
    CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142
    [Abstract] [Full Text] [Related]

  • 2. Riluzole: what it does to spinal and brainstem neurons and how it does it.
    Cifra A, Mazzone GL, Nistri A.
    Neuroscientist; 2013 Apr; 19(2):137-44. PubMed ID: 22596264
    [Abstract] [Full Text] [Related]

  • 3. Riluzole for the treatment of amyotrophic lateral sclerosis.
    Saitoh Y, Takahashi Y.
    Neurodegener Dis Manag; 2020 Dec; 10(6):343-355. PubMed ID: 32847483
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG, Mitchell JD, Lyon M, Moore DH.
    Cochrane Database Syst Rev; 2007 Jan 24; (1):CD001447. PubMed ID: 17253460
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pre- and postsynaptic mechanisms underlying inhibition of hypoglossal motor neuron excitability by riluzole.
    Bellingham MC.
    J Neurophysiol; 2013 Sep 24; 110(5):1047-61. PubMed ID: 23741042
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S, Lin CS, Cheah BC, Murray J, Menon P, Krishnan AV, Kiernan MC.
    Brain; 2013 May 24; 136(Pt 5):1361-70. PubMed ID: 23616585
    [Abstract] [Full Text] [Related]

  • 14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG, Mitchell JD, Moore DH.
    Cochrane Database Syst Rev; 2001 May 24; (4):CD001447. PubMed ID: 11687111
    [Abstract] [Full Text] [Related]

  • 15. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
    Noto Y, Shibuya K, Vucic S, Kiernan MC.
    Expert Rev Neurother; 2016 Oct 24; 16(10):1147-54. PubMed ID: 27314534
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis.
    Moujalled D, White AR.
    CNS Drugs; 2016 Mar 24; 30(3):227-43. PubMed ID: 26895253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.